» Articles » PMID: 33849968

The Evolving Epidemiology of Nasopharyngeal Carcinoma

Overview
Date 2021 Apr 14
PMID 33849968
Citations 132
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The epidemiology of nasopharyngeal carcinoma (NPC) has long been a source of fascination due to the malignancy's striking geographic distribution, the involvement of the oncogenic Epstein-Barr virus (EBV), the unique association with intake of Chinese-style salt-preserved fish, and etiologic heterogeneity by histologic subtype.

Methods: This review summarizes the current epidemiologic literature on NPC, highlighting recent results from our population-based case-control study in southern China.

Results: Findings from our case-control study provide new insight into the epidemiology of NPC, including a diminished role of Chinese-style salt-preserved fish, a profound impact of EBV genetic sequence variation, modest positive associations with passive smoking and household air pollution, and possible effects of oral health and the oral microbiome. Recent findings from other studies include a protective association with infectious mononucleosis, suggesting a causal role of early EBV infection; familial risk conferred by shared genetic variation in the host antibody-mediated immune response to EBV infection; and an unclear association with occupational exposure to formaldehyde.

Conclusions: To shed further light on the interplay of environmental, genetic, and viral causes of NPC, large pooled studies must accumulate sufficient cases with detailed exposure data.

Impact: New epidemiologic findings have reshaped the causal model for NPC.

Citing Articles

CircCENPM serves as a CeRNA to aggravate nasopharyngeal carcinoma metastasis and stemness via enhancing BMI1.

Wang R, Wang F Hereditas. 2025; 162(1):39.

PMID: 40087716 DOI: 10.1186/s41065-025-00406-7.


Nasopharyngeal masses in adults-A retrospective analysis of 255 patients to evaluate symptoms, clinical findings, and histological results.

von Witzleben M, von Witzleben A, Hoffmann T, Hahn J World J Otorhinolaryngol Head Neck Surg. 2025; 11(1):45-51.

PMID: 40070493 PMC: 11891276. DOI: 10.1002/wjo2.139.


Schisandrin B targets CDK4/6 to suppress proliferation and enhance radiosensitivity in nasopharyngeal carcinoma by inducing cell cycle arrest.

Fang Y, Lv X, Li G, Wang P, Zhang L, Wang R Sci Rep. 2025; 15(1):8452.

PMID: 40069371 PMC: 11897163. DOI: 10.1038/s41598-025-92992-9.


Clinical Outcomes for Nasopharyngeal Cancer in Non-Asian Patients: A Single-Center Experience.

Zahu R, Urian D, Manolescu V, Ungureanu A, Bodale C, Iacob A J Clin Med. 2025; 14(4).

PMID: 40004708 PMC: 11856680. DOI: 10.3390/jcm14041177.


Multi-Omics Characterization of Genome-Wide Abnormal DNA Methylation Reveals FGF5 as a Diagnosis of Nasopharyngeal Carcinoma Recurrence After Radiotherapy.

Long Z, Ding R, Quan T, Xu R, Huang Z, Wei D Biomolecules. 2025; 15(2).

PMID: 40001587 PMC: 11853517. DOI: 10.3390/biom15020283.